CHRISTOPHER JOHNSON: Open Payments
NPI 1205975448 · EAST SAINT LOUIS, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$714 in 46 payments from 10 companies in 2025. Trend: 2023 $308 · 2024 $341 · 2025 $714
Food & beverage: $714
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $207 |
| Alkermes, Inc. | 16 | $161 |
| Neurocrine BioSciences, Inc. | 4 | $91 |
| Teva Pharmaceuticals USA, Inc. | 2 | $66 |
| Axsome Therapeutics, Inc. | 2 | $50 |
| E.R. Squibb & Sons, L.L.C. | 3 | $43 |
| Almatica Pharma LLC | 2 | $37 |
| Vanda Pharmaceuticals Inc. | 2 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: INVEGA SUSTENNA, ARISTADA, INGREZZA, Auvelity, COBENFY, UZEDY, LOREEV XR, FANAPT.
Industry payments across IL — which companies pay providers there.
